ABBOTINDIAPharmaceuticals
Abbott India Ltd — Profit & Loss Statement
₹25915.00
-1.02%
Abbott India Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | -1.13 Cr | 0.40 Cr | 0.11 Cr | -0.17 Cr |
| EBIT | 1.90K Cr | 1.63K Cr | 1.29K Cr | 1.10K Cr |
| Tax Rate For Calcs | 0.25 | 0.26 | 0.25 | 0.26 |
| Normalized EBITDA | 1.97K Cr | 1.70K Cr | 1.36K Cr | 1.17K Cr |
| Total Unusual Items | -4.43 Cr | 1.54 Cr | 0.42 Cr | -0.67 Cr |
| Total Unusual Items Excluding Goodwill | -4.43 Cr | 1.54 Cr | 0.42 Cr | -0.67 Cr |
| Net Income From Continuing Operation Net Minority Interest | 1.41K Cr | 1.20K Cr | 949.41 Cr | 798.70 Cr |
| Reconciled Depreciation | 71.80 Cr | 71.17 Cr | 69.97 Cr | 66.10 Cr |
| Reconciled Cost Of Revenue | 3.51K Cr | 3.23K Cr | 2.98K Cr | 2.67K Cr |
| EBITDA | 1.97K Cr | 1.70K Cr | 1.36K Cr | 1.16K Cr |
| Net Interest Income | 247.29 Cr | 211.55 Cr | 128.07 Cr | 56.96 Cr |
| Interest Expense | 11.43 Cr | 12.45 Cr | 15.99 Cr | 19.10 Cr |
| Interest Income | 258.72 Cr | 224.00 Cr | 144.06 Cr | 76.06 Cr |
| Normalized Income | 1.42K Cr | 1.20K Cr | 949.10 Cr | 799.20 Cr |
| Net Income From Continuing And Discontinued Operation | 1.41K Cr | 1.20K Cr | 949.41 Cr | 798.70 Cr |
| Total Expenses | 4.76K Cr | 4.44K Cr | 4.20K Cr | 3.88K Cr |
| Rent Expense Supplemental | 0.27 Cr | 0.30 Cr | 0.26 Cr | 0.32 Cr |
| Diluted Average Shares | 2.12 Cr | 2.12 Cr | 2.12 Cr | 2.12 Cr |
| Basic Average Shares | 2.12 Cr | 2.12 Cr | 2.12 Cr | 2.12 Cr |
| Diluted EPS | 665.62 | 565.28 | 446.78 | 375.86 |
| Basic EPS | 665.62 | 565.28 | 446.78 | 375.86 |
| Diluted NI Availto Com Stockholders | 1.41K Cr | 1.20K Cr | 949.41 Cr | 798.70 Cr |
| Net Income Common Stockholders | 1.41K Cr | 1.20K Cr | 949.41 Cr | 798.70 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 1.41K Cr | 1.20K Cr | 949.41 Cr | 798.70 Cr |
| Net Income Including Noncontrolling Interests | 1.41K Cr | 1.20K Cr | 949.41 Cr | 798.70 Cr |
| Net Income Continuous Operations | 1.41K Cr | 1.20K Cr | 949.41 Cr | 798.70 Cr |
| Tax Provision | 472.51 Cr | 416.53 Cr | 324.41 Cr | 281.03 Cr |
| Pretax Income | 1.89K Cr | 1.62K Cr | 1.27K Cr | 1.08K Cr |
| Other Non Operating Income Expenses | 1.51 Cr | 1.63 Cr | 1.77 Cr | 1.68 Cr |
| Special Income Charges | -4.43 Cr | 1.54 Cr | 0.42 Cr | -0.67 Cr |
| Other Special Charges | -0.02 Cr | -2.98 Cr | -0.38 Cr | -0.74 Cr |
| Write Off | 4.45 Cr | 1.44 Cr | -0.04 Cr | 1.41 Cr |
| Net Non Operating Interest Income Expense | 247.29 Cr | 211.55 Cr | 128.07 Cr | 56.96 Cr |
| Interest Expense Non Operating | 11.43 Cr | 12.45 Cr | 15.99 Cr | 19.10 Cr |
| Interest Income Non Operating | 258.72 Cr | 224.00 Cr | 144.06 Cr | 76.06 Cr |
| Operating Income | 1.64K Cr | 1.41K Cr | 1.15K Cr | 1.03K Cr |
| Operating Expense | 1.25K Cr | 1.21K Cr | 1.22K Cr | 1.22K Cr |
| Other Operating Expenses | 252.45 Cr | 225.81 Cr | 234.03 Cr | 166.24 Cr |
| Depreciation And Amortization In Income Statement | 71.80 Cr | 71.17 Cr | 69.97 Cr | 66.10 Cr |
| Amortization | 1.98 Cr | 1.24 Cr | 1.28 Cr | 1.19 Cr |
| Depreciation Income Statement | 69.82 Cr | 69.93 Cr | 68.69 Cr | 64.91 Cr |
| Selling General And Administration | 341.40 Cr | 337.16 Cr | 349.64 Cr | 408.17 Cr |
| Selling And Marketing Expense | 192.93 Cr | 210.47 Cr | 217.97 Cr | 249.77 Cr |
| General And Administrative Expense | 148.47 Cr | 126.69 Cr | 131.67 Cr | 158.40 Cr |
| Rent And Landing Fees | 0.27 Cr | 0.30 Cr | 0.26 Cr | 0.32 Cr |
| Gross Profit | 2.90K Cr | 2.61K Cr | 2.36K Cr | 2.24K Cr |
| Cost Of Revenue | 3.51K Cr | 3.23K Cr | 2.98K Cr | 2.67K Cr |
| Total Revenue | 6.41K Cr | 5.85K Cr | 5.35K Cr | 4.91K Cr |
| Operating Revenue | 6.41K Cr | 5.85K Cr | 5.35K Cr | 4.91K Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Abbott India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.